Clinical trial
A Randomized Controlled Clinical Trial Evaluating the Efficacy of a Borate-based Bioactive Glass Advanced Wound Matrix and Standard of Care Versus Standard of Care Alone
NCT06403605 is registered in ClinicalTrials.gov with ETS Wound Care, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Clinical Trial Evaluating the Efficacy of a Borate-based Bioactive Glass Advanced Wound Matrix and Standard of Care Versus Standard of Care Alone
- Lead sponsor
- ETS Wound Care, LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 13, 2022
- Completion date
- January 17, 2025
- Enrollment
- 148 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot, diabetic foot ulcer, ulcer foot